226 related articles for article (PubMed ID: 32735534)
1. Onychomycosis: Current Understanding and Strategies for Enhancing Drug Delivery into Human Nail Tissue.
Aslam R; Hussain T; Yousaf AM; Ghori MU; Khan IU; Rizvi SAA; Shahzad Y
Curr Drug Res Rev; 2021; 13(1):25-35. PubMed ID: 32735534
[TBL] [Abstract][Full Text] [Related]
2. Transungual delivery of efinaconazole: its deposition in the nail of onychomycosis patients and in vitro fungicidal activity in human nails.
Sakamoto M; Sugimoto N; Kawabata H; Yamakawa E; Kodera N; Pillai R; Tatsumi Y
J Drugs Dermatol; 2014 Nov; 13(11):1388-92. PubMed ID: 25607707
[TBL] [Abstract][Full Text] [Related]
3. Emerging topical onychomycosis therapies - quo vadis?
Elkeeb R; Hui X; Murthy N; Maibach HI
Expert Opin Emerg Drugs; 2014 Dec; 19(4):489-95. PubMed ID: 25401504
[TBL] [Abstract][Full Text] [Related]
4. Chemical and physical strategies in onychomycosis topical treatment: A review.
Angelo T; Borgheti-Cardoso LN; Gelfuso GM; Taveira SF; Gratieri T
Med Mycol; 2017 Jul; 55(5):461-475. PubMed ID: 27703019
[TBL] [Abstract][Full Text] [Related]
5. Efinaconazole topical solution, 10%: formulation development program of a new topical treatment of toenail onychomycosis.
Bhatt V; Pillai R
J Pharm Sci; 2015 Jul; 104(7):2177-82. PubMed ID: 25940933
[TBL] [Abstract][Full Text] [Related]
6. Transungual delivery of terbinafine by iontophoresis in onychomycotic nails.
Nair AB; Vaka SR; Murthy SN
Drug Dev Ind Pharm; 2011 Oct; 37(10):1253-8. PubMed ID: 21457120
[TBL] [Abstract][Full Text] [Related]
7. Enhancing transungual delivery and spreading of efinaconazole under the nail plate through a unique formulation approach.
Kircik LH
J Drugs Dermatol; 2014 Dec; 13(12):1457-61. PubMed ID: 25607788
[TBL] [Abstract][Full Text] [Related]
8. Recent progress on the topical therapy of onychomycosis.
Alley MR; Baker SJ; Beutner KR; Plattner J
Expert Opin Investig Drugs; 2007 Feb; 16(2):157-67. PubMed ID: 17243936
[TBL] [Abstract][Full Text] [Related]
9. Novel nail penetration enhancer containing vesicles "nPEVs" for treatment of onychomycosis.
Bseiso EA; Nasr M; Sammour OA; Abd El Gawad NA
Drug Deliv; 2016 Oct; 23(8):2813-2819. PubMed ID: 26447337
[TBL] [Abstract][Full Text] [Related]
10. Treatment and management strategies of onychomycosis.
Aggarwal R; Targhotra M; Kumar B; Sahoo PK; Chauhan MK
J Mycol Med; 2020 Jun; 30(2):100949. PubMed ID: 32234349
[TBL] [Abstract][Full Text] [Related]
11. A Novel Vehicle for Enhanced Drug Delivery Across the Human Nail for the Treatment of Onychomycosis.
Turner R; Weaver S; Caserta F; Brown MB
Int J Pharm Compd; 2016; 20(1):71-80. PubMed ID: 27125057
[TBL] [Abstract][Full Text] [Related]
12. Dermatopharmacology of ciclopirox nail lacquer topical solution 8% in the treatment of onychomycosis.
Bohn M; Kraemer KT
J Am Acad Dermatol; 2000 Oct; 43(4 Suppl):S57-69. PubMed ID: 11051135
[TBL] [Abstract][Full Text] [Related]
13. Development of topical therapeutics for management of onychomycosis and other nail disorders: a pharmaceutical perspective.
Elsayed MM
J Control Release; 2015 Feb; 199():132-44. PubMed ID: 25481439
[TBL] [Abstract][Full Text] [Related]
14. Transungual delivery of ketoconazole using novel lacquer formulation.
Hafeez F; Hui X; Chiang A; Hornby S; Maibach H
Int J Pharm; 2013 Nov; 456(2):357-61. PubMed ID: 24029171
[TBL] [Abstract][Full Text] [Related]
15. New antifungal therapies for the treatment of onychomycosis.
Kumar S; Kimball AB
Expert Opin Investig Drugs; 2009 Jun; 18(6):727-34. PubMed ID: 19426118
[TBL] [Abstract][Full Text] [Related]
16. Onychomycosis: Diagnosis and management.
Singal A; Khanna D
Indian J Dermatol Venereol Leprol; 2011; 77(6):659-72. PubMed ID: 22016272
[TBL] [Abstract][Full Text] [Related]
17. Ungual and transungual drug delivery.
Shivakumar HN; Juluri A; Desai BG; Murthy SN
Drug Dev Ind Pharm; 2012 Aug; 38(8):901-11. PubMed ID: 22149347
[TBL] [Abstract][Full Text] [Related]
18. Design and development of a safer non-invasive transungual drug delivery system for topical treatment of onychomycosis.
Pal P; Thakur RS; Ray S; Mazumder B
Drug Dev Ind Pharm; 2015; 41(7):1095-9. PubMed ID: 24980914
[TBL] [Abstract][Full Text] [Related]
19. Transungual permeation: current insights.
Bhuptani RS; Deshpande KM; Patravale VB
Drug Deliv Transl Res; 2016 Aug; 6(4):426-39. PubMed ID: 26419676
[TBL] [Abstract][Full Text] [Related]
20. Drug delivery to the nail: therapeutic options and challenges for onychomycosis.
Barot BS; Parejiya PB; Patel HK; Mehta DM; Shelat PK
Crit Rev Ther Drug Carrier Syst; 2014; 31(6):459-94. PubMed ID: 25271773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]